Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Influenza, Human 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × FluMist × Clear all
NCT01474174 2018-07-03

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Wake Forest University Health Sciences

Completed
38 enrolled
CNS

Central Nervous System Neoplasms

NCT00906750 2011-10-13

FMRESP

St. Jude Children's Research Hospital

Phase 1 Completed
56 enrolled

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡